Fijen CA - Search Results

1

Antibody-dependent killing of meningococci by human neutrophils in serum of late complement component-deficient patients.

Platonov AE, Vershinina IV, Käyhty H, Fijen CA, Würzner R, Kuijper EJ. Platonov AE, et al. Among authors: fijen ca. Int Arch Allergy Immunol. 2003 Apr;130(4):314-21. doi: 10.1159/000070219. Int Arch Allergy Immunol. 2003. PMID: 12740533

2

Meningococcal disease and polymorphism of FcgammaRIIa (CD32) in late complement component-deficient individuals.

Platonov AE, Kuijper EJ, Vershinina IV, Shipulin GA, Westerdaal N, Fijen CA, van de Winkel JG. Platonov AE, et al. Among authors: fijen ca. Clin Exp Immunol. 1998 Jan;111(1):97-101. doi: 10.1046/j.1365-2249.1998.00484.x. Clin Exp Immunol. 1998. PMID: 9472667 Free PMC article.

3

[The bactericidal action of human neutrophils on meningococci in vitro].

Platonov AE, Vershinina IV, Käyhty H, Fijen CA, Kuijper EJ. Platonov AE, et al. Among authors: fijen ca. Zh Mikrobiol Epidemiol Immunobiol. 1999 May-Jun;(3):46-52. Zh Mikrobiol Epidemiol Immunobiol. 1999. PMID: 10851990 Russian.

4

Development of antibodies against tetravalent meningococcal polysaccharides in revaccinated complement-deficient patients.

Drogari-Apiranthitou M, Fijen CA, Van De Beek D, Hensen EF, Dankert J, Kuijper EJ. Drogari-Apiranthitou M, et al. Among authors: fijen ca. Clin Exp Immunol. 2000 Feb;119(2):311-6. doi: 10.1046/j.1365-2249.2000.01130.x. Clin Exp Immunol. 2000. PMID: 10632668 Free PMC article.

5

Complement deficiency predisposes for meningitis due to nongroupable meningococci and Neisseria-related bacteria.

Fijen CA, Kuijper EJ, Tjia HG, Daha MR, Dankert J. Fijen CA, et al. Clin Infect Dis. 1994 May;18(5):780-4. doi: 10.1093/clinids/18.5.780. Clin Infect Dis. 1994. PMID: 8075270

6

The effect of mannan-binding lectin on opsonophagocytosis of Neisseria meningitidis.

Drogari-Apiranthitou M, Fijen CA, Thiel S, Platonov A, Jensen L, Dankert J, Kuijper EJ. Drogari-Apiranthitou M, et al. Among authors: fijen ca. Immunopharmacology. 1997 Dec;38(1-2):93-9. doi: 10.1016/s0162-3109(97)00081-7. Immunopharmacology. 1997. PMID: 9476120

7

Characterization of Neisseria meningitidis strains causing disease in complement-deficient and complement-sufficient patients.

Fijen CA, Kuijper EJ, Dankert J, Daha MR, Caugant DA. Fijen CA, et al. J Clin Microbiol. 1998 Aug;36(8):2342-5. doi: 10.1128/JCM.36.8.2342-2345.1998. J Clin Microbiol. 1998. PMID: 9666019 Free PMC article.

8

Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine.

Fijen CA, Kuijper EJ, Drogari-Apiranthitou M, Van Leeuwen Y, Daha MR, Dankert J. Fijen CA, et al. Clin Exp Immunol. 1998 Dec;114(3):362-9. doi: 10.1046/j.1365-2249.1998.00738.x. Clin Exp Immunol. 1998. PMID: 9844044 Free PMC article. Clinical Trial.

9

Assessment of complement deficiency in patients with meningococcal disease in The Netherlands.

Fijen CA, Kuijper EJ, te Bulte MT, Daha MR, Dankert J. Fijen CA, et al. Clin Infect Dis. 1999 Jan;28(1):98-105. doi: 10.1086/515075. Clin Infect Dis. 1999. PMID: 10028078

10

The role of Fcgamma receptor polymorphisms and C3 in the immune defence against Neisseria meningitidis in complement-deficient individuals.

Fijen CA, Bredius RG, Kuijper EJ, Out TA, De Haas M, De Wit AP, Daha MR, De Winkel JG. Fijen CA, et al. Clin Exp Immunol. 2000 May;120(2):338-45. doi: 10.1046/j.1365-2249.2000.01208.x. Clin Exp Immunol. 2000. PMID: 10792385 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters